Validation of Micro Capillary Blood for Use in the Athlete Biological Passport

Anti-doping sample collection and analysis have evolved since the introduction of the first World Anti-Doping Code. Most of the changes introduced by revisions to the Code have focused on analysis rather than sample collection methods. Changes to collection methods have the potential to impact pre-analytical and/or analytical variance. Therefore, validation of capillary collection devices is important to the integrity and success of the athlete biological passport (ABP). Paired capillary and venous samples (n = 220) were collected from athletes during out-of-competition (OOC) tests and analyzed for ABP markers. Data from the OOC trial were pooled with previous data collected under laboratory conditions and during an in-competition setting. Across the pooled dataset (n = 300), capillary and venous measurements showed strong agreement for the primary ABP markers. Deming regression supported close alignment between methods, with slopes near 1.0 and intercepts near 0. Bland-Altman analysis indicated minimal bias and no evidence of systematic divergence across the observed measurement ranges. ABP profiles were created for 19 athletes who contributed more than one set of paired samples to the dataset. When inserted into ABP profiles, differences between capillary and venous blood had minimal impact on upper and lower limits of the adaptive model. Capillary blood collection is a valid and interchangeable method of blood collection for ABP purposes and presents a significant advancement in athlete-centered anti-doping protocols. The introduction of the 2027 Code and International Standards paves the way for implementation of an optimal anti-doping experience for athletes without compromising scientific integrity.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2026-11-14
DOI
https://doi.org/10.1002/dta.70188
Primary Topic
Doping in Sports
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Validation of Micro Capillary Blood for Use in the Athlete Biological Passport

Laura A. Garvican‐Lewis, Yvette Dehnes, Jakob Mørkeberg, Geoffrey D. Miller et al.
Drug Testing and Analysis
Doping in Sports
article

Validation of Micro Capillary Blood for Use in the Athlete Biological Passport

Laura A. Garvican‐Lewis, Yvette Dehnes, Jakob Mørkeberg, Geoffrey D. Miller, Jenna M. Goodrum, Lasse Baekken
article en

Abstract

Anti-doping sample collection and analysis have evolved since the introduction of the first World Anti-Doping Code. Most of the changes introduced by revisions to the Code have focused on analysis rather than sample collection methods. Changes to collection methods have the potential to impact pre-analytical and/or analytical variance. Therefore, validation of capillary collection devices is important to the integrity and success of the athlete biological passport (ABP). Paired capillary and venous samples (n = 220) were collected from athletes during out-of-competition (OOC) tests and analyzed for ABP markers. Data from the OOC trial were pooled with previous data collected under laboratory conditions and during an in-competition setting. Across the pooled dataset (n = 300), capillary and venous measurements showed strong agreement for the primary ABP markers. Deming regression supported close alignment between methods, with slopes near 1.0 and intercepts near 0. Bland-Altman analysis indicated minimal bias and no evidence of systematic divergence across the observed measurement ranges. ABP profiles were created for 19 athletes who contributed more than one set of paired samples to the dataset. When inserted into ABP profiles, differences between capillary and venous blood had minimal impact on upper and lower limits of the adaptive model. Capillary blood collection is a valid and interchangeable method of blood collection for ABP purposes and presents a significant advancement in athlete-centered anti-doping protocols. The introduction of the 2027 Code and International Standards paves the way for implementation of an optimal anti-doping experience for athletes without compromising scientific integrity.

Drug Testing and Analysis
United States Anti-Doping Agency (US)
Doping in Sports
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon